Cleared Traditional

K251193 - Grafton™ DBM (FDA 510(k) Clearance)

Also includes:
Grafton Plus™ DBM Paste Magnifuse™ Bone Graft
Jun 2025
Decision
56d
Days
Class 2
Risk

K251193 is an FDA 510(k) clearance for the Grafton™ DBM. This device is classified as a Filler, Bone Void, Calcium Compound (Class II - Special Controls, product code MQV).

Submitted by Medtronic Sofamor Danek, Inc. (Memphis, US). The FDA issued a Cleared decision on June 12, 2025, 56 days after receiving the submission on April 17, 2025.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.

Submission Details

510(k) Number K251193 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 17, 2025
Decision Date June 12, 2025
Days to Decision 56 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MQV — Filler, Bone Void, Calcium Compound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3045